$258 Million

Constellation Pharmaceuticals, Inc.

Follow-on Offering

Bookrunner, December 2019

Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals is a clinical stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer.